The WHO’s COVID-19 Technology Access Pool (C-TAP) and the UN-backed Medicines Patent Pool on Aug. 29 announced a licensing agreement with Taiwan’s Medigen Vaccine Biologics Corp to make the company’s COVID-19 vaccine accessible worldwide to people in need.
This is the first time a Taiwanese vaccine manufacturer has used the WHO patent access model to offer its know-how for a COVID-19 vaccine to the world. WHO Director-General Tedros Adhanom Ghebreyesus expressed his gratitude to Medigen for sharing its patent to support countries in fighting the disease.
Toxicology results, animal and clinical trial data, as well as production data, were required to enter the C-TAP pool, similar to how Taiwanese officials in 2021 assessed and granted emergency use authorization (EUA) for the product.
Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) said that the WHO’s addition of Medigen’s vaccine, which has been administered more than 3 million times in seven countries, means that the global body has authorized and endorsed a Taiwan-made vaccine, and was an affirmation of the nation’s vaccine industry. This is a validation of Medigen after the harsh criticism it has endured from Taiwanese opposition parties over the past few years.
There are also lessons to learn about the restoration of justice for vaccine development and manufacturing in Taiwan.
During the COVID-19 pandemic, China weaponized vaccines to advance its geopolitical agenda and influence politics in Taiwan. Beijing not only barred vaccines produced by foreign manufacturers and limited its people to its domestic vaccines, it also sought to block Taiwan’s vaccine procurement, including by delaying delivery of an order for BioNTech vaccines. These actions aimed to inflict political damage on President Tsai Ing-wen’s (蔡英文) administration while promoting Chinese-made vaccines to facilitate its “united front” work.
Ironically, despite surveys showing that more than 80 percent of Taiwanese were not willing to be inoculated with China-made vaccines, some opposition politicians, notably from the Chinese Nationalist Party (KMT), and pro-China media influencers badgered the government to buy Chinese vaccines, while lashing out at Taiwan’s domestically produced vaccine and stigmatizing efforts to foster an indigenous biotech industry.
International researchers have shown that Taiwan-made vaccines are effective against COVID-19. A transnational study published in a Swiss medical journal found that Medigen’s vaccine has an efficacy of 84 percent, far better than Chinese vaccines, which were rated only 65 percent effective.
While the Food and Drug Administration was criticized for granting Medigen an EUA based on immunobridging, many WHO-validated vaccines used the same standard to issue EUAs. Studies have also shown that Medigen’s protein subunit vaccine has fewer adverse reactions than mRNA COVID-19 vaccines.
The Medigen story is a reminder that the scientific process should prevail over political mudslinging.
Political attacks have intensified in the run-up to the presidential and legislative elections in January, with slogans such as “Electing the Democratic Progressive Party will cause war” — even as China continues with its military posturing in the Taiwan Strait.
Just as collective immunity against a virus is required to protect public health when a pandemic hits, collective awareness and wisdom are required as the elections draw near to guard against disinformation and stigmatization, and protect Taiwan’s democracy and sovereignty.
The Chinese Nationalist Party (KMT) has a good reason to avoid a split vote against the Democratic Progressive Party (DPP) in next month’s presidential election. It has been here before and last time things did not go well. Taiwan had its second direct presidential election in 2000 and the nation’s first ever transition of political power, with the KMT in opposition for the first time. Former president Chen Shui-bian (陳水扁) was ushered in with less than 40 percent of the vote, only marginally ahead of James Soong (宋楚瑜), the candidate of the then-newly formed People First Party (PFP), who got almost 37
The three teams running in January’s presidential election were finally settled on Friday last week, but as the official race started, the vice-presidential candidates of the Chinese Nationalist Party (KMT) and the Taiwan People’s Party (TPP) have attracted more of the spotlight than the presidential candidates in the first week. After the two parties’ anticipated “blue-white alliance” dramatically broke up on the eve of the registration deadline, the KMT’s candidate, New Taipei City Mayor Hou You-yi (侯友宜), the next day announced Broadcasting Corp of China chairman Jaw Shaw-kong (趙少康) as his running mate, while TPP Chairman and presidential candidate Ko Wen-je
On Tuesday, Taiwan’s TAIEX stock index peaked at 17,360 points and closed at 17,341 points, surpassing Hong Kong’s Hang Seng Index, which fell to 17,303 points and closed at 17,541 points. A few years ago, the gap between the Taiwanese and Hong Kong stock indices was more than 20,000 points, but this was before the 2019 anti-extradition protests. Hong Kong is one of the world’s most important financial centers, but many Chinese Internet users joke that it is only a ruin today. When asked by a legislative councilor whether he would communicate with social media platforms in the mainland to request
Chinese Nationalist Party (KMT) presidential candidate and New Taipei City Mayor Hou You-yi (侯友宜) has called on his Democratic Progressive Party (DPP) counterpart, William Lai (賴清德), to abandon his party’s Taiwanese independence platform. Hou’s remarks follow an article published in the Nov. 30 issue of Foreign Affairs by three US-China relations academics: Bonnie Glaser, Jessica Chen Weiss and Thomas Christensen. They suggested that the US emphasize opposition to any unilateral changes in the “status quo” across the Taiwan Strait, and that if Lai wins the election, he should consider freezing the Taiwanese independence clause. The concept of de jure independence was first
RSS